̖ | ˎƷQ | ͨ | a | Ҏ | λ | r |
122150 | _m | ̹Ƭ | rQ(Ϻ)˾ | 500mg*30Ƭ | 300 | |
120720 | ͨ | ĪƬ | Glaxo Operations UK Ltd. | 50mg*30Ƭ | 122 | |
120998 | R | WƽƬ | Novartis Pharma Schweiz AG | 300mg*50Ƭ | 228 | |
122149 | _m | ̹Ƭ | rQ(Ϻ)˾ | 250mg*30Ƭ | 180 | |
120292 | °ͽ | cƬ | ِZưfˎ˾ | 500mg*30Ƭ | 77.6 | |
120997 | R | WƽƬ | Novartis Farma S.p.A | 150mg*50Ƭ | 128 | |
122228 | e | ĪƬ | Fˎ؟ι˾ | 25mg*48Ƭ | 75 | |
121228 | ̩ | Ƭ | ɭˎ˾ | 100mg*60Ƭ | ƿ | 284 |
120290 | RƽƬ | ZAˎ˾ | 0.2g*30Ƭ | 31.3 | ||
220392 | dBƽƬ | dBƽƬ | ĴZϿˎ˾ | 0.3g*100Ƭ | 41 | |
122294 | ʰ | WƽƬ | ĭhˎ˾ | 0.3g*30Ƭ | 108 | |
121229 | ̩ | Ƭ | ɭˎ˾ | 25mg*60Ƭ | ƿ | 95 |
231335 | dBz | dBz | ˎIͬˎ˾ | 0.3g*60 | 93 | |
141020 | R | WƽڷҺ | Novartis Pharma S.A.S. | 250ml | ƿ | 380 |
221149 | 悰BƬ | 悰BƬ | ʡˎIɷ˾ | 0.4g*24Ƭ | 67 | |
221079 | 悰BƬ | 悰BƬ | ʡˎIɷ˾ | 0.4g*12Ƭ*2*2 | 112 | |
130325 | ͡ | Ӱ͇z | Ktˎɷ˾ | 0.1g*10*5 | 50 | |
220027 | dBƬ | dBƬ | ˎS˾ | 0.3g*12Ƭ*4 | 138 | |
230621 | ຣXˎˎIɷ˾ | 0.3g*12*2 | 39.3 | |||
140250 | °ͽ | cǝ{ | ِZʥˎ˾ | 300ml:12g | 83.2 | |
250504 | tB | tB | lˎɷ˾ | 6g*8 | 158 | |
230677 | B | tB | Aˎ؟ι˾ | 3g*6*2С | 137 | |
220371 | 悰BƬ | 悰BƬ | ϺSˎI˾ | 0.36g*100Ƭ | 25 | |
230676 | B | tB | Aˎ؟ι˾ | 15g*3ƿ | 86 | |
121826 | Ӣdͣ | ͷͱ廯cƬ | ʡtԺˎS | 12*2*2С | 192 | |
131147 | z | xˎ˾ | 75mg*8 | 95 | ||
131148 | z | xˎ˾ | 150mg*8 | 160 | ||
231338 | L | L | xԪˎI˾ | 0.12g*90*3ƿ | 360 |
һ 1 һ β 퓴Σ1/1 50ƪ/ D |